Filing Details

Accession Number:
0001088020-13-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-05 16:56:36
Reporting Period:
2013-02-01
Filing Date:
2013-02-05
Accepted Time:
2013-02-05 16:56:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
911216 Palatin Technologies Inc PTN Pharmaceutical Preparations (2834) 954078884
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304773 W Alan Dunton Palatin Technologies, Inc.
4B Cedar Brook Drive
Cranbury NJ 08512
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-01 1,000 $0.58 5,520 No 4 P Indirect By SEP IRA and Danerius LLC
Common Stock Acquisiton 2013-02-01 1,000 $0.59 6,520 No 4 P Indirect By SEP IRA and Danerius LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By SEP IRA and Danerius LLC
No 4 P Indirect By SEP IRA and Danerius LLC
Footnotes
  1. Of the 6,520 shares reported, 2,000 are owned by Dr. Dunton's SEP IRA and 4,520 are owned by Danerius LLC. Dr. Dunton is the majority owner and president of Danerius LLC, a consulting company for the pharmaceutical industry.